Rakovina Therapeutics Inc. | Finanzwire

Basculer en Français

10100	Companies
206781	Keywords
136916	Articles
109586	Press releases

Headlines Articles Press releases Rakovina Therapeutics Inc.

Home
Companies
Rakovina Therapeutics Inc.

BRIEF

published on 04/02/2025 at 15:36, 11 months 23 days ago

Rakovina Therapeutics Receives Buy Rating from First Berlin Equity Research

Artificial Intelligence DNA Damage Response Rakovina Therapeutics PARP And ATR Biotech Investment
PRESS RELEASE

published on 04/02/2025 at 15:31, 11 months 23 days ago

Original-Research: Rakovina Therapeutics Inc. (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research initiates coverage on Rakovina Therapeutics Inc. with a Buy recommendation and CAD 0.40 target price. Rakovina focuses on DNA Damage Response pathways in developing next-gen cancer treatments

First Berlin Equity Research Buy Recommendation Rakovina Therapeutics Inc. DNA Damage Response Pathways CAD 0.40 Target Price

Accesswire

Published on 03/26/2026 at 14:05, 1 hour 19 minutes ago

SouthGobi Announces Profit Warning
Published on 03/26/2026 at 13:00, 2 hours 24 minutes ago

Prospect Ridge Strengthens Technical Team with Appointment of Phil Smerchanski as Senior Technical Advisor
Published on 03/26/2026 at 13:00, 2 hours 24 minutes ago

GameSquare's Stream Hatchet Launches Creator Communities to Manage the Full Creator Marketing Lifecycle
Published on 03/26/2026 at 12:59, 2 hours 25 minutes ago

Adcore Concludes Fiscal Year 2025 With Strong Q4 Performance
Published on 03/26/2026 at 12:45, 2 hours 39 minutes ago

Quartz Mountain Reports Strong Warrant Exercise Participation and Provides Exploration Update at Maestro Project, Central British Columbia

View all ACCESSWIRE

EQS Group

Published on 03/26/2026 at 15:05, 18 minutes ago

JOY GROUP Announces 2025 Financial Results, Revenue Surpasses US$620M
Published on 03/26/2026 at 15:01, 22 minutes ago

EQS-Adhoc: CENIT AG decides to switch from the Regulated Market (Prime Standard) to the Scale Segment of the Frankfurt Stock Exchange
Published on 03/26/2026 at 15:00, 24 minutes ago

OLB’s financial performance remains at a consistently high level
Published on 03/26/2026 at 14:35, 48 minutes ago

Guidepoint Library Surpasses 100,000 Transcripts, Scaling Real-Time Access to Expert Knowledge
Published on 03/26/2026 at 14:30, 54 minutes ago

Delticom publishes Annual Report 2025: Revenues slightly higher than last year, dividend proposal of € 0.12 per share

Les Echos

Published on 03/26/2026 at 08:57, 6 hours 26 minutes ago

Edenred statement
Published on 03/26/2026 at 07:30, 7 hours 54 minutes ago

BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/25/2026 at 18:53, 20 hours 30 minutes ago

LNA SANTE : 2025 Annual Results
Published on 03/25/2026 at 18:31, 20 hours 53 minutes ago

Strong investment performance and active roll-out of our strategy
Published on 03/25/2026 at 17:45, 21 hours 39 minutes ago

Combined General Meeting on May 05, 2026: publication of the notice of Meeting

View all LES ECHOS COMFI WIRE